Emergent BioSolutions Inc. (EBS) Financial Analysis & Valuation | Quarter Chart

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biolo... more
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and re... more

Company facts

Reported company information and share structure.

Company Share structure
Market Cap$350.85MExchangeNYSE
SectorHealthcareIndustryBiotechnology
CountryUSCEOJoseph C. Papa Jr.
IPO Date2006-11-15CAGR12.36%
Employees900Websitewww.emergentbiosolutions.com
Div. YieldPayout Ratio
Buy Back Yield3.26%Total Yield3.26%
EBS chart loading...

Key metrics

Reported fundamentals and market-derived technical indicators.

Fundamentals Technicals
EV$951.39MP/E4.72Forward P/E6.5PEG
P/S1.56P/B3.2P/CF43.27P/FCF80.81
Sales$770.20MSales 1Y-9.56%Sales 3Y-28.17%Sales 5Y-54.92%
EPS$1.44EPS 1Y-245.32%EPS 3Y-70.65%EPS 5Y-164%
Sales QoQ50.1%EPS QoQ-4797.17%Sales QoQ Avg20.86%EPS QoQ Avg-1408.06%
Gross Margin49.4%Operating Margin-7.06%Profit Margin-22.96%ROCE-5.47%
ROA-16%ROE-36%Altman Z Score0.84Piotroski Score6
Current Ratio5.42Quick Ratio2.95Cash Ratio1.14Op. CF Ratio-0.13
Debt/Equity1.7Debt/Assets0.52Lt Debt/Equity1.7Lt Debt/Cap.0.63
Intrst Cov.-1.07Inventory Turnover1.28Asset Turnover0.69Receivables Turnover4.05
Enterprise Value$951.39MP/E Ratio4.72
Forward P/E6.5PEG Ratio
P/S Ratio1.56P/B Ratio3.2
P/CF Ratio43.27P/FCF Ratio80.81
EPS$1.44EPS Growth 1Y-245.32%
EPS Growth 3Y-70.65%EPS Growth 5Y-164%
Revenue Growth 1Y-9.56%Gross Margin49.4%
Operating Margin-7.06%Profit Margin-22.96%
ROE-36%ROA-16%
ROCE-5.47%Current Ratio5.42
Quick Ratio2.95Cash Ratio1.14
Debt/Equity1.7Interest Coverage-1.07
Altman Z Score0.84Piotroski Score6